Skip to main content
Erschienen in: Annals of Nuclear Medicine 8/2015

01.10.2015 | Original Article

Evaluation of a revised version of computer-assisted diagnosis system, BONENAVI version 2.1.7, for bone scintigraphy in cancer patients

verfasst von: Mitsuru Koizumi, Noriaki Miyaji, Taisuke Murata, Kazuki Motegi, Kenta Miwa, Masamichi Koyama, Takashi Terauchi, Kei Wagatsuma, Kazunori Kawakami, Jens Richter

Erschienen in: Annals of Nuclear Medicine | Ausgabe 8/2015

Einloggen, um Zugang zu erhalten

Abstract

Objective

BONENAVI is a computer-assisted diagnosis system that analyzes bone scintigraphy automatically. We experienced more than a few segmentation errors with the previous BONENAVI version (2.0.5). We have since obtained a revised version (2.1.7) and evaluate it.

Methods

Bone scans of patients were analyzed by BONENAVI version 2.0.5 and a revised version 2.1.7 with regard to segmentation errors, sensitivity, and specificity. Patients with skeletal metastases from prostate cancer, lung cancer, breast cancer, and other cancers were included in the study as true-positive cases. Patients with no skeletal metastasis (regardless of hot spots), and patients with abnormal bone scans but no skeletal metastasis were included as negative cases. Bone-scan patients were subjected to artificial neural network (ANN) evaluation. Values equal to or above 0.5 were regarded as positive, and those below 0.5 as negative. The patients whose clinical status did not correspond to their ANN scores were assessed for any similarities.

Results

The frequency of segmentation errors was statistically significantly reduced when using BONENAVI version 2.1.7. The differences in sensitivity and specificity for the results of version 2.0.5 versus version 2.1.7 were not different, giving a high Cohen’s kappa coefficient. In the patients who showed an increased ANN value with version 2.1.7, a few false-positive thoracic lesions were identified. Patients whose ANN value was significantly high with version 2.0.5 showed no tendencies.

Conclusion

Revised BONENAVI version 2.1.7 for bone scintigraphy was superior with regard to segmentation errors. However, its sensitivity and specificity were similar to those of version 2.0.5. The false-positive identification of thoracic lesions in revised version 2.1.7 might be subject to remedy.
Literatur
1.
Zurück zum Zitat Imbriaco M, Larson SM, Yeung HW, Mawlawi OR, Erdi Y, Venkatraman ES, et al. A new parameter for measuring metastatic bone involvement by prostate cancer: the bone scan index. Clin Cancer Res. 1998;4:1765–72.PubMed Imbriaco M, Larson SM, Yeung HW, Mawlawi OR, Erdi Y, Venkatraman ES, et al. A new parameter for measuring metastatic bone involvement by prostate cancer: the bone scan index. Clin Cancer Res. 1998;4:1765–72.PubMed
2.
Zurück zum Zitat Sadik M, Jakobsson D, Olofsson F, Ohlsson M. Suurkula, Edenbrandt L: a new computer-based decision-support system for the interpretation of bone scans. Nucl Med Commun. 2006;27:417–23.CrossRefPubMed Sadik M, Jakobsson D, Olofsson F, Ohlsson M. Suurkula, Edenbrandt L: a new computer-based decision-support system for the interpretation of bone scans. Nucl Med Commun. 2006;27:417–23.CrossRefPubMed
3.
Zurück zum Zitat Sadik M, Suurkula M, Hoglund P, Jarund A, Edenbrandt L. Quality of planar whole-body bone scan interpretation—a nationwide survey. Eur J Nucl Med Mol Imaging. 2008;35:1464–72.CrossRefPubMed Sadik M, Suurkula M, Hoglund P, Jarund A, Edenbrandt L. Quality of planar whole-body bone scan interpretation—a nationwide survey. Eur J Nucl Med Mol Imaging. 2008;35:1464–72.CrossRefPubMed
4.
Zurück zum Zitat Sadik M, Hamadeh I, Nordblom P, Suurkula M, Hoglund P, Phlsson M, et al. Computer-assisted interpretation of planar whole-body bone scans. J Nucl Med. 2008;49:1958–65.CrossRefPubMed Sadik M, Hamadeh I, Nordblom P, Suurkula M, Hoglund P, Phlsson M, et al. Computer-assisted interpretation of planar whole-body bone scans. J Nucl Med. 2008;49:1958–65.CrossRefPubMed
5.
Zurück zum Zitat Horikoshi H, Kikuchi A, Onoguchi M, Sjostrand K, Edenbrandt L. Computer-aided diagnosis system for bone scintigrams from Japanese patients: importance of training database. Ann Nucl Med. 2012;26:622–6.PubMedCentralCrossRefPubMed Horikoshi H, Kikuchi A, Onoguchi M, Sjostrand K, Edenbrandt L. Computer-aided diagnosis system for bone scintigrams from Japanese patients: importance of training database. Ann Nucl Med. 2012;26:622–6.PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Nakajima K, Nakajima Y, Horikoshi H, Ueno M, Wakabayashi H, Shiga T, et al. Enhanced diagnostic accuracy of quantitative bone scan using an artificial neural network system: a Japanese multi-center database project. Eur J Nucl Med Mol Imaging Res. 2013;3:83. Nakajima K, Nakajima Y, Horikoshi H, Ueno M, Wakabayashi H, Shiga T, et al. Enhanced diagnostic accuracy of quantitative bone scan using an artificial neural network system: a Japanese multi-center database project. Eur J Nucl Med Mol Imaging Res. 2013;3:83.
7.
Zurück zum Zitat Koizumi M, Wagatsuma K, Miyaji N, Murata T, Miwa K, Takiguchi T, et al. Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting. Ann Nucl Med. 2015;29:128–48. Koizumi M, Wagatsuma K, Miyaji N, Murata T, Miwa K, Takiguchi T, et al. Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting. Ann Nucl Med. 2015;29:128–48.
8.
Zurück zum Zitat Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S, et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer. 1988;61:195–202.CrossRefPubMed Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S, et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer. 1988;61:195–202.CrossRefPubMed
9.
Zurück zum Zitat Ulmert D, Kabateh R, Fox JJ, Savage C, Evans MJ, Lilja H, et al. A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the bone scan index. Eur Urol. 2012;62:78–84.PubMedCentralCrossRefPubMed Ulmert D, Kabateh R, Fox JJ, Savage C, Evans MJ, Lilja H, et al. A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the bone scan index. Eur Urol. 2012;62:78–84.PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Meirelles GSP, Schoder H, Ravizzini GC, Gonen M, Fox JJ, Humm J, et al. Prognostic value of baseline F-18 fluorodeoxyglucose positron emission tomography and Tc-99 m MDP bone scan in progressing metastatic prostate cancer. Clin Cancer Res. 2010;16:6093–9.PubMedCentralCrossRefPubMed Meirelles GSP, Schoder H, Ravizzini GC, Gonen M, Fox JJ, Humm J, et al. Prognostic value of baseline F-18 fluorodeoxyglucose positron emission tomography and Tc-99 m MDP bone scan in progressing metastatic prostate cancer. Clin Cancer Res. 2010;16:6093–9.PubMedCentralCrossRefPubMed
11.
Zurück zum Zitat Dennis ER, Jia X, Mezheritskiy IS, Stephenson RD, Schoder H, Fox JJ, et al. Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer. J Clin Oncol. 2012;30:519–24.PubMedCentralCrossRefPubMed Dennis ER, Jia X, Mezheritskiy IS, Stephenson RD, Schoder H, Fox JJ, et al. Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer. J Clin Oncol. 2012;30:519–24.PubMedCentralCrossRefPubMed
Metadaten
Titel
Evaluation of a revised version of computer-assisted diagnosis system, BONENAVI version 2.1.7, for bone scintigraphy in cancer patients
verfasst von
Mitsuru Koizumi
Noriaki Miyaji
Taisuke Murata
Kazuki Motegi
Kenta Miwa
Masamichi Koyama
Takashi Terauchi
Kei Wagatsuma
Kazunori Kawakami
Jens Richter
Publikationsdatum
01.10.2015
Verlag
Springer Japan
Erschienen in
Annals of Nuclear Medicine / Ausgabe 8/2015
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-015-0988-0

Weitere Artikel der Ausgabe 8/2015

Annals of Nuclear Medicine 8/2015 Zur Ausgabe